BNET Industries

ImClone Systems Inc.

(IMCL) is in the Pharma Industry

Last Fiscal Year Sales:$590.8M
  • Public
  • US
Dow Jones Description

We are a biopharmaceutical company whose mission is to advance oncology care by developing and commercializing a portfolio of targeted treatments designed to address the medical needs of patients with cancer. We focus on what we believe are two promising strategies for treating cancer: growth factor blockers and angiogenesis inhibitors. We were incorporated under the laws of the State of Delaware on April 26, 1984. Our corporate headquarters and research facility are located at 180 Varick Street, New York, New York 10014 and our telephone number is (212) 645-1405. We make available free of charge on our Internet website (http://www.imclone.com) our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission. In addition, our Internet website includes other items related to corporate governance matters, including among other things, our corporate governance guidelines, charters of the various committees of the Board of Directors, and our corporate compliance program (including our Code of Business Conduct and Ethics). ...

Chairman and Chief Executive OfficerJames M. Cornelius
Number of Employees 1,128
Contact Information

180 Varick Street

New York, New York 10014

imclone.com

212.645.1405

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Another Reason to Hate Big Pharma's M&A

    5/12/09 - Merger / Acquisition - View Story

  • 13D Filings

    2/17/09 - Merger / Acquisition - View Story

  • Carl Icahn makes move, boosts stake in Amylin

    1/31/09 - Merger / Acquisition - View Story

  • ImClone deal drags Lilly's 4Q profits

    1/30/09 - Merger / Acquisition - View Story

  • Merck CEO: Acquisitions are key priority for 2009

    1/07/09 - Merger / Acquisition - View Story

News & Analysis

imclone systems inc. - All News and Analysis

Those who viewed this also viewed...

Decision Makers

Name (plus bio) Position
John H. Johnson Chief Executive Officer
Samuel D. Waksal President
Eric K. Rowinsky Chief Medical Officer
Kenneth J. Zuerblis Senior Vice President & CFO
Ana I. Stancic Senior Vice President, Finance
Daniel J. O'Connor Senior Vice President, General Counsel & Secretary
Kenneth William Powell Andrew Senior Vice President, General Counsel
Larry Witte Senior Vice President, Research
Michael Bailey Senior Vice President, Commercial Operations
Peter Bohlen Senior Vice President, Res
Richard Crowley Senior Vice President, Biopharmaceutical Operations
Ronald A. Martell Senior Vice President, Commercial Operations
Andrea F. Rabney Vice President, Corp Communications
Charles Dunne Vice President, MIS & Facilities
Daniel Hicklin Vice President, Experimental Therapeutics
David M. Pitts Assistant Vice President, Corp Communications
David Schloss Vice President, Human Resources
Douglas E. Swan Vice President, Field Operations
Gary Paulter Vice President, Engineering & Facilities
Jeff Skulsky Vice President
Joan Connolly Associate Vice President, Strategy & Operations
John B. Landes Vice President, Business Development
Joseph Depinto Vice President, Commercial Operations
Lisa M. Cammy Vice President, HR
Marc Labelle Vice President
Margaret Dalesandro Vice President, Project Management
Margery B. Fischbein Vice President
Nikhil Mehta Vice President, CMC Regulatory Affairs
Paul A. Goldstein Vice President, Finance Operations
Peter R. Borzilleri Vice President, Internal Audit
Thomas C. Gallagher Vice President, Intellectual Property
Vivienne E. Arasi Vice President
Bernhard Ehmer Senior Vice President & Managing Director, Int'L Operations
Harlan W. Waksal Founder
Jason E. Farber Director, Corp Communications

Board of Directors

Name (plus bio) Position
James M. Cornelius Chairman and Chief Executive Officer
Jules Haimovitz Chairman
Robert F Goldhammer Chairman of The Board of Directors
Alexander J. Denner Board of Directors
Andrew R.J. Bonfield Board of Directors
Charles Woler Board of Directors
David Sidransky Vice Chairman
John E. Celentano Board of Directors
Peter S. Liebert Board of Directors
Richard Mulligan Board of Directors
Thomas F. Deuel Board of Directors
Vincent T. Devita Jr. Board of Directors
Organization Position Status
ImClone Systems Incorporated Chairman and Chief Executive Officer Current
Organization Position Status
ImClone Systems Incorporated Chief Executive Officer Current
Organization Position Status
ImClone Systems Incorporated President Current

Dr. Rowinsky has served as a director since February 2008. Dr. Rowinsky currently serves as Executive Vice President of Clinical Development and Regulatory at ImClone Systems Incorporated, a wholly-owned subsidiary of Eli Lilly and Company. Prior to joining ImClone Systems in 2005, Dr. Rowinsky focused his academic efforts in cancer drug development as the Director of Clinical Research and later Director of the Institute for Drug Development of the Cancer Therapy and Research Center in San Antonio and the SBC Endowed Chair for Early Drug Development from 1996 to 2005. He was also Clinical Professor of Medicine in the Division of Medical Oncology at the University of Texas Health Science Center at San Antonio from 1996 to 2006. From 1987 to 1996, Dr. Rowinsky served as an Associate Professor of Oncology at the Johns Hopkins University School of Medicine. He was a longstanding NCI principal investigator on U01 anticancer drug development grants and integrally involved in pivotal clinical and preclinical investigations which led to the development of paclitaxel, docetaxel, topotecan, irinotecan, erlotinib and gefitinib, among others. Dr. Rowinsky is the Editor-in-Chief of Investigational New Drugs, an Associate Editor and/or Editorial Board Member of Cancer Research (Associate Editor and Reviews Editor), Clinical Cancer Research, Annals of Oncology, Cancer Biology and Therapy and several other oncology journals and has published over 270 manuscripts in both the preclinical and clinical research fields. He has also served on the Scientific Advisory Board and Project Advisory Boards of a large number of pharmaceutical and biotechnology companies and has advised and/or presented aspects of New Drug Applications to the FDA on several occasions. Dr. Rowinsky's honors include receipt of the career development award of the American Cancer Society and the 6th Annual Emil J. Freireich Award for outstanding achievement of a young researcher in clinical cancer therapeutics. He also served on the Board of Scientific Counselors of the National Cancer Institute. Dr. Rowinsky received his B.A. degree from New York University and his M.D. from the Vanderbilt University School of Medicine. Following his residency in internal medicine at the University of California, he completed fellowship training in medical oncology at the Johns Hopkins University School of Medicine.

Organization Position Status
ImClone Systems Incorporated Chief Medical Officer Current
ImClone Systems Incorporated Executive Vice President of Clinical Development and Regulatory Current
Supratek Pharma Inc Board of Directors Current
Adventrx Pharmaceuticals Inc Director Current
Institute for Drug Development Director of Clinical Research Former
Johns Hopkins University School of Medicine Associate Professor of Oncology Former
University of Texas Health Science Center at San Antonio Clinical Professor of Medicine Former
The Johns Hopkins University Associate Prof of Oncology Former
Vanderbilt University School of Medicine M.D. Former
New York University B.A. Degree Former

Mr. Zuerblis owned no shares of the Company's stock at June 30, 2008, nor did he have any options exercisable prior to August 29, 2008.

Organization Position Status
ImClone Systems Incorporated Senior Vice President & CFO Current
Organization Position Status
ImClone Systems Incorporated Senior Vice President, Finance Current
Organization Position Status
ImClone Systems Incorporated Senior Vice President, General Counsel & Secretary Current
Organization Position Status
ImClone Systems Incorporated Senior Vice President, General Counsel Current
Organization Position Status
ImClone Systems Incorporated Senior Vice President, Research Current
Organization Position Status
ImClone Systems Incorporated Senior Vice President, Commercial Operations Current
Organization Position Status
ImClone Systems Incorporated Senior Vice President, Res Current
Organization Position Status
ImClone Systems Incorporated Senior Vice President, Biopharmaceutical Operations Current
Organization Position Status
ImClone Systems Incorporated Senior Vice President, Commercial Operations Current
Organization Position Status
ImClone Systems Incorporated Vice President, Corp Communications Current
Organization Position Status
ImClone Systems Incorporated Vice President, MIS & Facilities Current
Organization Position Status
ImClone Systems Incorporated Vice President, Experimental Therapeutics Current
Organization Position Status
ImClone Systems Incorporated Assistant Vice President, Corp Communications Current
Organization Position Status
ImClone Systems Incorporated Vice President, Human Resources Current
Organization Position Status
ImClone Systems Incorporated Vice President, Field Operations Current
Organization Position Status
ImClone Systems Incorporated Vice President, Engineering & Facilities Current
Organization Position Status
ImClone Systems Incorporated Vice President Current
Organization Position Status
ImClone Systems Incorporated Associate Vice President, Strategy & Operations Current
Organization Position Status
ImClone Systems Incorporated Vice President, Business Development Current
Organization Position Status
ImClone Systems Incorporated Vice President, Commercial Operations Current
Organization Position Status
ImClone Systems Incorporated Vice President, HR Current
Organization Position Status
ImClone Systems Incorporated Vice President Current
Organization Position Status
ImClone Systems Incorporated Vice President, Project Management Current
Organization Position Status
ImClone Systems Incorporated Vice President Current
Organization Position Status
ImClone Systems Incorporated Vice President, CMC Regulatory Affairs Current
Organization Position Status
ImClone Systems Incorporated Vice President, Finance Operations Current
Organization Position Status
ImClone Systems Incorporated Vice President, Internal Audit Current
Organization Position Status
ImClone Systems Incorporated Vice President, Intellectual Property Current
Organization Position Status
ImClone Systems Incorporated Vice President Current
Organization Position Status
ImClone Systems Incorporated Senior Vice President & Managing Director, Int'L Operations Current
Organization Position Status
ImClone Systems Incorporated Founder Current
Senesco Technologies Inc. Board of Directors Current
Montclair Art Museum Board of Directors Current
Oberlin College Board of Directors Current
ImClone Systems Incorporated Director Former
Tufts University School of Medicine M.D. Former
Oberlin College Bachelor of Arts In Biology Former
Organization Position Status
ImClone Systems Incorporated Director, Corp Communications Current
ImClone Systems Incorporated Director, Corp Communications Former
Shell Oil Company geophysicist Former
Organization Position Status
Dick Clark Productions, Inc. Managing Director Current
The Brooklyn College Foundation, Inc Trustee Current
ImClone Systems Incorporated Chairman Current
Blockbuster, Inc. Board of Directors Current
Dick Clark Productions, Inc. Vice Chairman Current
InfoSpace, Inc. Board of Directors Current
King World Productions, Inc. President and Chief Operating Officer Former
Brooklyn College M.A. degree in Mathematics Former
Organization Position Status
Broadsword Partners, LLC Co-Founder Current
Community Connect, Inc. Chairman Current
ImClone Systems Incorporated Chairman of The Board of Directors Current
Broadsword Partners, LLC Board of Directors Current
The Boston Stock Exchange Inc. Chairman Former
Kidder, Peabody & Co. Vice Chairman of the Board of Directors Former
Boston University Former
Organization Position Status
Adventrx Pharmaceuticals Inc Board of Directors Current
Hypermed, Inc. Director Current
ImClone Systems Incorporated Board of Directors Current
ImClone Systems Incorporated Chairman Former
Yale University M.Phil. Former
Organization Position Status
Bristol-Myers Squibb Company Executive Vice President & Chief Financial Officer Current
Bristol-Myers Squibb Company Senior Vice President Current
Boc Limited Non-Executive Director Current
ImClone Systems Incorporated Board of Directors Current
Bristol-Myers Squibb Company Board of Directors Former
Organization Position Status
Duke Street Capital Operating Partner Current
ImClone Systems Incorporated Board of Directors Current
GlaxoSmithKline Plc Former
Organization Position Status
ImClone Systems Incorporated Vice Chairman Current
ImClone Systems Incorporated Board of Directors Current
Organization Position Status
ImClone Systems Incorporated Board of Directors Current
Organization Position Status
ImClone Systems Incorporated Board of Directors Current
Cadus Corp Director Current
Organization Position Status
ImClone Systems Incorporated Board of Directors Current
Organization Position Status
ImClone Systems Incorporated Board of Directors Current
Organization Position Status
ImClone Systems Incorporated Board of Directors Current

Executive News

  • Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

    Pharma Live - 6/09/09 - View Story

  • Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors

    PR Newswire - 6/09/09 - View Story

  • Icahn Claims Biogen Board Seats

    The Wall Street Journal Interactive Edition - 6/04/09 - View Story

  • Biogen, Icahn board fight down to the wire

    CNN Money - 6/03/09 - View Story

  • UPDATE 4-Biogen counting votes, but Icahn claims 2 seats

    Forbes.com - 6/03/09 - View Story

  • REFILE-UPDATE 2-Biogen recesses holder vote, Icahn cries foul

    Forbes.com - 6/03/09 - View Story

  • Biogen says vote not counted, Icahn claims 2 seats

    Reuters - 6/03/09 - View Story

  • Biogen recesses shareholder vote, Icahn cries foul

    Reuters - 6/03/09 - View Story

  • Biogen calls break in contested shareholder parley

    Reuters - 6/03/09 - View Story

  • Amylin critics oust 2 board leaders

    SignOn San Diego - 6/02/09 - View Story

advertisement
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement